/ Summary table of transactions by the Company in Publicis Groupe SA shares in 2022
Deliveries of free share plans | Deliveries of stock options | Purchases (liquidity contract) | Sales (liquidity contract) | |||
---|---|---|---|---|---|---|
At December 31, 2022 | Quantities (in shares) | Quantities (in shares) | Quantities (in shares) | Average price (in euros) | Quantities (in shares) | Average price (in euros) |
Under the 20th resolution of the General Shareholders’ Meeting of May 26, 2021 | 1,089,222 | 175,876 | 2,193,000 | 56.99 | 2,135,000 | 57.41 |
Under the 17th resolution of the General Shareholders’ Meeting of May 25, 2022 | 0 | 281,431 | 1,972,911 | 51.47 | 2,026,487 | 51.81 |
Total | 1,089,222 | 457,307 | 4,165,911 | 54.38 | 4,161,487 | 54.69 |
At December 31, 2022, Publicis Groupe SA owned 2,319,795 shares with a nominal value of euro 0.40, representing 0.91% of its own share capital, for an overall cost price of euro 137,795,802 and an average price per share of euro 59.40. These shares are broken down into 57,924 shares held under the liquidity contract and 2,261,871 shares allocated to free share or stock option plans.
The description of this program presented below, prepared in accordance with article 241-3 of the General Regulation of the AMF, will not be the subject of a specific publication, in the event of the implementation of a share buyback program.
As the authorization granted to the Management Board by the General Meeting of May 25, 2022 to trade in the Company’s shares will expire on November 25, 2023, the shareholders will be asked to approve the draft 18th resolution of the General Shareholders’ Meeting of May 31, 2023 and to once again authorize the Management Board to trade in the Company’s shares.
This authorization would be granted for a period of 18 months from the General Shareholders’ Meeting of May 31, 2023 and would supersede, as from that same date, for the unused portion at that date, the authorization granted to the Management Board to trade in the Company’s shares by the General Shareholders’ Meeting of May 25, 2022.
This authorization would enable the Management Board to acquire a maximum of 10% of the Company’s share capital in order to: